• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Tonix Pharmaceuticals Holding Corp. (TNXP)

    -NasdaqGM
    2.29 Down 0.06(2.55%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development10,671  9,490  10,314  8,871  
    Selling General and Administrative3,343  3,912  2,966  2,913  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,014) (13,402) (13,280) (11,784)
    Income from Continuing Operations
    Total Other Income/Expenses Net38  42   -   -  
    Earnings Before Interest And Taxes(13,976)(13,360)(13,250)(11,763)
    Interest Expense -   -   -   -  
    Income Before Tax(13,976)(13,360)(13,250)(11,763)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(13,976)(13,360)(13,250)(11,763)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (13,976) (13,360) (13,250) (11,763)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (13,976) (13,360) (13,250) (11,763)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.